about
sameAs
Postmarketing study of cardiovascular adverse reactions associated with sumatriptanUse and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors.Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxaneThe haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans?Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619Sumatriptan therapy for headache and acute myocardial infarction.QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 1: review of serotonergic cardiac adverse events with a triptan case.Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.Sumatriptan for the treatment of migraine attacks--a review of controlled clinical trials.Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro.Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.Cardiorespiratory distress after sumatriptan given by injectionCoronary vasospasm and sumatriptan.Oral sumatriptan-induced myocardial infarction.Coronary vasospasm and sumatriptan.
P2860
Q28378384-DA6FF654-4743-44B4-AE36-0AB5BD1ECCEEQ30584718-B93FA1E1-4B6E-466A-86D2-5EC56F4B20DBQ34373285-92ABEDFC-6D55-4742-B2BA-B008C1CB2C82Q34481198-D35BB459-7EFB-4816-9573-3DD151B08396Q35189866-70776731-3B8B-4B16-8E9B-4B76FD8B54CBQ35802749-2411F30F-4AC0-4309-977C-F659A793ED48Q35872811-759D2E14-8789-4838-B998-176CC6C4D832Q35884789-92D00660-D14D-4D74-AA91-CC60CC05F293Q36053195-8F059729-D41C-4500-AF4E-7329CAED4093Q36055018-EC3CAAE9-58F0-4268-B261-C0B447CE25E3Q36330430-1D175154-F281-4D1F-9991-B1530222F98FQ37803238-1617703A-F0D6-40DE-B4DB-2B908E0C1257Q38065274-D11CA619-0A8A-4F50-8E00-43F43443C194Q39471681-054DCBF2-0880-4B34-86F8-54956E6CBE58Q40857948-60F5F160-D262-46A9-996F-763FAC8C7EDEQ41289268-4AACB035-744B-40A6-8B13-97437F24A5F3Q42185809-8403D9E9-73C0-4AED-B4B2-8EC2A2E013CEQ42538062-12CE0981-7611-4B8F-82F4-094F6377F4B8Q42762902-F06F21DF-F8CD-45B0-9AB7-98E3A89B1309Q42763297-CAB73E3C-64B3-4C06-A060-388BD7A63EBDQ45055014-D8E03D0A-AB46-4B39-8946-9BD8C4F385B5Q46129997-B6320E4D-A731-4B6F-8B5A-9CF1026134D4
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Coronary vasospasm induced by subcutaneous sumatriptan
@ast
Coronary vasospasm induced by subcutaneous sumatriptan
@en
Coronary vasospasm induced by subcutaneous sumatriptan
@nl
type
label
Coronary vasospasm induced by subcutaneous sumatriptan
@ast
Coronary vasospasm induced by subcutaneous sumatriptan
@en
Coronary vasospasm induced by subcutaneous sumatriptan
@nl
prefLabel
Coronary vasospasm induced by subcutaneous sumatriptan
@ast
Coronary vasospasm induced by subcutaneous sumatriptan
@en
Coronary vasospasm induced by subcutaneous sumatriptan
@nl
P2093
P1433
P1476
Coronary vasospasm induced by subcutaneous sumatriptan
@en
P2093
P356
10.1136/BMJ.304.6839.1415
P407
P577
1992-05-30T00:00:00Z